Author information from the last article
Seksjon for klinisk immunologi og infeksjonssykdommer
Oslo universitetssykehus
og
Universitetet i Oslo
Forfatterbidrag: utforming, utarbeiding, revisjon og godkjenning av innsendte manusversjon.
Børre Fevang er overlege og professor.
Articles by Børre Fevang
Vaccination of immunosuppressed patients
- Marton König,
- Trygve Holmøy,
- Gro Owren Nygaard,
- Jon Riise,
- Karsten Midtvedt,
- Guro Løvik Goll,
- Kristin Kaasen Jørgensen,
- Ludvig A. Munthe,
- Børre Fevang,
- Anders Eivind Myhre,
- Marius Trøseid
13.04.2026:
Chronically ill patients with a weak immune system are at increased risk of severe infections, often as a result of immunomodulatory therapy rather than the underlying disease. Many patients in this group exhibit reduced vaccine responses and require tailored vaccination regimens. Following the...
Necrotising soft tissue infection in the head and neck region, 2017–2023
- Nadja Tanovic,
- Ellen Kvestad,
- Trine Kåsine,
- Gorm Hansen,
- Børre Fevang
27.10.2025:
Necrotising soft tissue infections are severe and potentially fatal bacterial infections of the skin and soft tissues. Patients with comorbidities such as diabetes or immunodeficiency are particularly at risk (1, 2). There are no internationally accepted diagnostic criteria, and the nomenclature is...
COVID-19 patients treated with convalescent plasma
- Lise Sofie Haug Nissen-Meyer,
- Magnhild Eide Macpherson,
- Linda Gail Skeie,
- Marte Hvalryg,
- Abid Hussain Llohn,
- Tine Torsvik Steinsvåg,
- Mona Høysæter Fenstad,
- Anders Tveita,
- Einar K. Kristoffersen,
- Tatjana Sundic,
- Fridtjof Lund-Johansen,
- John Torgils Vaage,
- Øystein Flesland,
- Anne Ma Dyrhol-Riise,
- Jan Cato Holter,
- Tor Audun Hervig,
- Børre Fevang
03.08.2023:
COVID-19 convalescent plasma (NORPLASMA) (1) first became available to Norwegian patients in the spring of 2020. The Norwegian Directorate of Health recommended use of the product in patients who were at risk of developing a severe/life-threatening course of COVID-19, where the attending doctor...
COVID-19 convalescent plasma from Norwegian blood donors
- Lise Sofie Haug Nissen-Meyer,
- Tor Hervig,
- Børre Fevang,
- Gunnstein Norheim,
- Anne-Marte Bakken Kran,
- John Torgils Vaage,
- Øystein Flesland
14.06.2022:
The collection and use of convalescent plasma to treat COVID-19 has taught us important lessons about the organisation, testing and selection of blood donors and patients. This is knowledge that can be used in the next pandemic. Convalescent plasma is plasma taken from survivors of a severe...